相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improving Tumor Accumulation of Aptamers by Prolonged Blood Circulation
Ding Ding et al.
ANALYTICAL CHEMISTRY (2020)
Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges
Fen He et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Pharmacokinetics and Pharmacodynamics of the Small Interfering Ribonucleic Acid, Givosiran, in Patients With Acute Hepatic Porphyria
Sagar Agarwal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
A sensitive thrombin-linked sandwich immunoassay for protein targets using high affinity phosphorodithioate modified aptamer for thrombin labeling
Chao Wang et al.
TALANTA (2020)
A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified Mice
Zhenjian Zhuo et al.
ADVANCED SCIENCE (2020)
Recent Advances in Aptamer Discovery and Applications
Yang Zhang et al.
MOLECULES (2019)
In Vitro Selection of Circular DNA Aptamers for Biosensing Applications
Meng Liu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Spotlight Commentary: Medicines use during pregnancy and harmful effects on offspring
Li Wei et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Olaptesed pegol (NOX-A12) with bendamustine and rituximab: a phase IIa study in patients with relapsed/refractory chronic lymphocytic leukemia
Michael Steurer et al.
HAEMATOLOGICA (2019)
Nanocomposites as biomolecules delivery agents in nanomedicine
Magdalena Bamburowicz-Klimkowska et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing
Bo-Ya Liu et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Differential binding cell-SELEX method to identify cell-specific aptamers using high-throughput sequencing
Karlis Pleiko et al.
SCIENTIFIC REPORTS (2019)
Size-Tunable Assemblies Based on Ferrocene-Containing DNA Polymers for Spatially Uniform Penetration
Jie Tan et al.
CHEM (2019)
Regulation of Protein Activity and Cellular Functions Mediated by Molecularly Evolved Nucleic Acids
Jie Tan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Integrated Assessment of the Clinical Performance of GalNAc3-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2019)
Anti-PEG Antibodies Inhibit the Anticoagulant Activity of PEGylated Aptamers
Angelo Moreno et al.
CELL CHEMICAL BIOLOGY (2019)
Albumin Hitchhiking with an Evans Blue Analog for Cancer Theranostics
Emily B. Ehlerding et al.
THERANOSTICS (2018)
Floxuridine Homomeric Oligonucleotides Hitchhike with Albumin InSitu for Cancer Chemotherapy
Cheng Jin et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Selection of PD1/PD-L1 X-Aptamers
Hongyu Wang et al.
BIOCHIMIE (2018)
Annealing novel nucleobase-lipids with oligonucleotides or plasmid DNA based on H-bonding or π-π interaction: Assemblies and transfections
Yuan Ma et al.
BIOMATERIALS (2018)
Acute hepatotoxicity of 2′ fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins
Wen Shen et al.
NUCLEIC ACIDS RESEARCH (2018)
Current Advances in Aptamers for Cancer Diagnosis and Therapy
Shin-ichiro Hori et al.
CANCERS (2018)
Aptamer-based targeted therapy
Guizhi Zhu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Aptamer-guided nanomedicines for anticancer drug delivery
Walhan Alshaer et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
An integrated microfluidic platform to perform uninterrupted SELEX cycles to screen affinity reagents specific to cardiovascular biomarkers
Anirban Sinha et al.
BIOSENSORS & BIOELECTRONICS (2018)
Modified aptamers enable quantitative sub-10-nm cellular DNA-PAINT imaging
Sebastian Strauss et al.
NATURE METHODS (2018)
In Aptamers They Trust: Caveats of the SOMAscan Biomarker Discovery Platform From SomaLogic
Abhishek Joshi et al.
CIRCULATION (2018)
Aptamer-iRNAs as Therapeutics for Cancer Treatment
Mario M. Soldevilla et al.
PHARMACEUTICALS (2018)
Pharmacokinetics, pharmacodynamics and safety of aptamers
Katarina D. Kovacevic et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
High-Affinity DNA Aptamer Generation Targeting von Willebrand Factor A1-Domain by Genetic Alphabet Expansion for Systematic Evolution of Ligands by Exponential Enrichment Using Two Types of Libraries Composed of Five Different Bases
Ken-ichiro Matsunaga et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Multivalent Aptamer-RNA Conjugates for Simple and Efficient Delivery of Doxorubicin/siRNA into Multidrug-Resistant Cells
Hyosook Jeong et al.
MACROMOLECULAR BIOSCIENCE (2017)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Shuaijian Ni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Aptamer-based liposomes improve specific drug loading and release
Kevin Plourde et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Circular Bivalent Aptamers Enable in Vivo Stability and Recognition
Hailan Kuai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Chemical modification improves the stability of the DNA aptamer GBI-10 and its affinity towards tenascin-C
Kunfeng Li et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2017)
A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
Fangfei Li et al.
NATURE COMMUNICATIONS (2017)
Aptamers for CD Antigens: From Cell Profiling to Activity Modulation
Amin Nozari et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma
Chao Liang et al.
BIOMATERIALS (2017)
Aptamer-Modified Tetrahedral DNA Nanostructure for Tumor-Targeted Drug Delivery
Qianshun Li et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Aptamer-siRNA Chimeras: Discovery, Progress, and Future Prospects
Sven Kruspe et al.
BIOMEDICINES (2017)
Tracing the Therapeutic Process of Targeted Aptamer/Drug Conjugate on Cancer Cells by Surface-Enhanced Raman Scattering Spectroscopy
Rong Deng et al.
ANALYTICAL CHEMISTRY (2017)
Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment
Yi Liu et al.
BIOCONJUGATE CHEMISTRY (2016)
Advancements in Aptamer Discovery Technologies
Michael R. Gotrik et al.
ACCOUNTS OF CHEMICAL RESEARCH (2016)
Albumin-Binding Evans Blue Derivatives for Diagnostic Imaging and Production of Long-Acting Therapeutics
Orit Jacobson et al.
BIOCONJUGATE CHEMISTRY (2016)
Conjugation of mono and di-GalNAc sugars enhances the potency of antisense oligonucleotides via ASGR mediated delivery to hepatocytes
Garth A. Kinberger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
readat: An R package for reading and working with SomaLogic ADAT files
Richard J. Cotton et al.
BMC BIOINFORMATICS (2016)
Safety, pharmacokinetics and pharmacodynamics of the anti-hepcidin Spiegelmer lexaptepid pegol in healthy subjects
M. Boyce et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system
Pei Jing et al.
CANCER LETTERS (2016)
A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells
Carla L. Esposito et al.
JOURNAL OF CONTROLLED RELEASE (2016)
An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
Kyun Heo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Comprehensive Structure-Activity Relationship of Triantennary N-Acetylgalactosamine Conjugated Antisense Oligonucleotides for Targeted Delivery to Hepatocytes
Thazha P. Prakash et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Peter L. Turecek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells
Christopher H. Stuart et al.
NANOMEDICINE (2016)
Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells
Juntao Tan et al.
NANOSCALE RESEARCH LETTERS (2016)
Evoking picomolar binding in RNA by a single phosphorodithioate linkage
N. Dinuka Abeydeera et al.
NUCLEIC ACIDS RESEARCH (2016)
A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2016)
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
Mario Martinez Soldevilla et al.
ONCOTARGET (2016)
Chemical Conjugation of Evans Blue Derivative: A Strategy to Develop Long-Acting Therapeutics through Albumin Binding
Haojun Chen et al.
THERANOSTICS (2016)
Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells
Juntao Tan et al.
NANOSCALE RESEARCH LETTERS (2016)
Disposition and Pharmacology of a GalNAc3-conjugated ASO Targeting Human Lipoprotein (a) in Mice
Rosie Z. Yu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
From selection hits to clinical leads: progress in aptamer discovery
Keith E. Maier et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Bioconjugates for targeted delivery of therapeutic oligonucleotides
Xin Ming et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Target-Responsive DNA Hydrogel Mediated Stop-Flow Microfluidic Paper-Based Analytic Device for Rapid, Portable and Visual Detection of Multiple Targets
Xiaofeng Wei et al.
ANALYTICAL CHEMISTRY (2015)
Aptamer-Drug Conjugates
Guizhi Zhu et al.
BIOCONJUGATE CHEMISTRY (2015)
Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer therapeutics
Axel Vater et al.
DRUG DISCOVERY TODAY (2015)
Evolution of Functional Six-Nucleotide DNA
Liqin Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Self-assembly of DNA Nanohydrogels with Controllable Size and Stimuli-Responsive Property for Targeted Gene Regulation Therapy
Juan Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars
Duncan Hieu M. Dam et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy
Chao Liang et al.
NATURE MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras
Nithya Subramanian et al.
NUCLEIC ACID THERAPEUTICS (2015)
DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition
Xiaoqiu Wu et al.
THERANOSTICS (2015)
Pharmacokinetics of a Cholesterol-conjugated Aptamer Against the Hepatitis C Virus (HCV) NS5B Protein
Chang Ho Lee et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
Walhan Alshaer et al.
BIOCONJUGATE CHEMISTRY (2015)
Au@Pt Nanoparticle Encapsulated Target-Responsive Hydrogel with Volumetric Bar-Chart Chip Readout for Quantitative Point-of-Care Testing
Zhi Zhu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas
Liyu Li et al.
BIOMATERIALS (2014)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Expanding the Potential of G-Quadruplex Structures: Formation of a Heterochiral TBA Analogue
Antonella Virgilio et al.
CHEMBIOCHEM (2014)
Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor
Shashi Gupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
Andreas Herrmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Automated Modular Synthesis of Aptamer-Drug Conjugates for Targeted Drug Delivery
RuoWen Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Multivalent N-Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing
Jayaprakash K. Nair et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Carla L. Esposito et al.
MOLECULAR THERAPY (2014)
Aptamer-targeted Antigen Delivery
Brian C. Wengerter et al.
MOLECULAR THERAPY (2014)
Sequence motifs associated with hepatotoxicity of locked nucleic acid-modified antisense oligonucleotides
Andrew D. Burdick et al.
NUCLEIC ACIDS RESEARCH (2014)
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2014)
Stability and bioactivity of thrombin binding aptamers modified with D-/L-isothymidine in the loop regions
Baobin Cai et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy
Brett Schrand et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Nucleic Acid Aptamers: New Methods for Selection, Stabilization, and Application in Biomedical Science
Hoon Young Kong et al.
BIOMOLECULES & THERAPEUTICS (2013)
The effects of the anti-hepcidin Spiegelmer NOX-H94 on inflammation-induced anemia in cynomolgus monkeys
Frank Schwoebel et al.
BLOOD (2013)
Aptamers from Cell-Based Selection for Bioanalytical Applications
Weihong Tan et al.
CHEMICAL REVIEWS (2013)
Use of Oligonucleotide Aptamer Ligands to Modulate the Function of Immune Receptors
Eli Gilboa et al.
CLINICAL CANCER RESEARCH (2013)
Target-Responsive Sweet Hydrogel with Glucometer Readout for Portable and Quantitative Detection of Non-Glucose Targets
Ling Yan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
A Novel C5a-neutralizing Mirror-image (L-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis
Kai Hoehlig et al.
MOLECULAR THERAPY (2013)
Generation of high-affinity DNA aptamers using an expanded genetic alphabet
Michiko Kimoto et al.
NATURE BIOTECHNOLOGY (2013)
Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
Hang Xing et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Targeting von Willebrand factor as a novel anti-platelet therapy; Application of ARC1779, an Anti-vWF aptamer, against thrombotic risk
Ok-Nam Bae
ARCHIVES OF PHARMACAL RESEARCH (2012)
Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
Hsin-I Chang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer
Ling Meng et al.
PLOS ONE (2012)
Polyvalent nucleic acid aptamers and modulation of their activity: a focus on the thrombin binding aptamer
Domenica Musumeci et al.
PHARMACOLOGY & THERAPEUTICS (2012)
The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome
John Paul Vavalle et al.
FUTURE CARDIOLOGY (2012)
Release of Photoactivatable Drugs from Plasmonic Nanoparticles for Targeted Cancer Therapy
Yun-Ling Luo et al.
ACS NANO (2011)
Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
Emily K. Waters et al.
BLOOD (2011)
Bi-specific Aptamers Mediating Tumor Cell Lysis
Achim Boltz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Determination of Target Sequence Bound by PapX, Repressor of Bacterial Motility, in flhD Promoter Using Systematic Evolution of Ligands by Exponential Enrichment (SELEX) and High Throughput Sequencing
Daniel J. Reiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Development of aptamer therapeutics
David H. J. Bunka et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Expanding the Chemistry of DNA for in Vitro Selection
Jonathan D. Vaught et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
In vivo selection of tumor-targeting RNA motifs
Jing Mi et al.
NATURE CHEMICAL BIOLOGY (2010)
The emerging field of RNA nanotechnology
Peixuan Guo
NATURE NANOTECHNOLOGY (2010)
Aptamers as therapeutics
Anthony D. Keefe et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes
Zehui Cao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Molecular Assembly of an Aptamer-Drug Conjugate for Targeted Drug Delivery to Tumor Cells
Yu-Fen Huang et al.
CHEMBIOCHEM (2009)
Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers
Rakesh N. Veedu et al.
MOLECULAR BIOSYSTEMS (2009)
A Hybrid DNA Aptamer-Dendrimer Nanomaterial for Targeted Cell Labeling
Jing Zhou et al.
MACROMOLECULAR BIOSCIENCE (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Micromagnetic selection of aptamers in microfluidic channels
Xinhui Lou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Late onset of Cc12 blockade with the spiegelmer mNOX-E36-3′PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice
Volha Ninichuk et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Aptamers in immunotherapy
Claudia M. Dollins et al.
HUMAN GENE THERAPY (2008)
Engineering target-responsive hydrogels based on aptamer - Target interactions
Huanghao Yang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells
Prabodhika Mallikaratchy et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to Anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer
K. Eszter Borbas et al.
BIOCONJUGATE CHEMISTRY (2007)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
EWM Ng et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform
Vaishali Bagalkot et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Direct in vitro selection of a 2 '-O-methyl aptamer to VEGF
PE Burmeister et al.
CHEMISTRY & BIOLOGY (2005)
Proximity extension of circular DNA aptamers with real-time protein detection
DA Di Giusto et al.
NUCLEIC ACIDS RESEARCH (2005)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacokinetics and biodistribution of novel aptamer compositions
JM Healy et al.
PHARMACEUTICAL RESEARCH (2004)
Construction, stability, and activity of multivalent circular anticoagulant aptamers
DA Di Giusto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Progress in thioaptamer development
XB Yang et al.
CURRENT DRUG TARGETS (2004)
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
KS Schmidt et al.
NUCLEIC ACIDS RESEARCH (2004)
LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
F Darfeuille et al.
NUCLEIC ACIDS RESEARCH (2004)
Spiegelmers: Biostable aptamers
D Eulberg et al.
CHEMBIOCHEM (2003)
A DNA Spiegelmer to staphylococcal enterotoxin B
WG Purschke et al.
NUCLEIC ACIDS RESEARCH (2003)
Cellular uptake, distribution, and stability of 10-23 deoxyribozymes
CR Dass et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2002)
Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood
H Dougan et al.
NUCLEAR MEDICINE AND BIOLOGY (2000)
分享论文
